Salute e Benessere

IBA Reports Half Year 2024 Results

GROUP REVENUES UP 21.9%ACCELERATED BACKLOG CONVERSION IN PROTON THERAPY AND OTHER ACCELERATORS STRONG GROSS MARGIN IMPROVEMENT AND BREAKEVEN REBITLouvain-la-Neuve, Belgium, 29 August 2024- IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2024.(EUR 000)H1 2024H1 2023VarianceVariance %Total Revenues206 452 ​ 169 418 ​ 37 034 ​21.9%​ Proton...
Nasdaq GlobeNewswire
29/08/2024

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate…

To further strengthen its commitment to healthcare and biopharmaceuticals, LOTTE Holdings has newly established a CVC dedicated to these fields. This CVC aims to gather cutting-edge insights to accelerate access to innovative technologies and promote investment in promising startups. In this first phase of investment, the CVC aims to target companies of all stages globally. To further strengthen its commitment to healthcare and biopharmaceuticals, LOTTE Holdings has newly established a CVC...
PR Newswire
29/08/2024

LG OPENS NEW CHAPTER IN CONNECTED HOME LIVING WITH "THINQ ON" AI HOME HUB AT IFA…

The AI home hub seamlessly connects with a vast array of appliances and Internet of Things (IoT) devices, making it easy for anyone to configure and enjoy a personalized AI-powered home. Powered by LG's unique Affectionate Intelligence, the ThinQ ON continuously learns from individual usage patterns and broader usage trends to tailor customers' daily experiences, accelerating the realization of LG's "Zero Labor Home" vision. The AI home hub seamlessly connects with a vast array of…
PR Newswire
29/08/2024

Global Surgical Staplers Market to Surpass ~USD 8 Billion Mark by 2030 |…

Key Takeaways from the Surgical Staplers Market Report Key Takeaways from the Surgical Staplers Market Report To read more about the latest highlights related to the surgical staplers market, get a snapshot of the key highlights entailed in the Global Surgical Staplers Market Report Surgical Staplers Overview Surgical staplers are advanced medical devices used to close wounds or surgical incisions by placing surgical staples. Unlike traditional suturing, which requires...
PR Newswire
28/08/2024

Peripheral Neuropathic Pain Market to Exhibit Growth at a CAGR of 4.1% by 2034 |…

Key Takeaways from the Peripheral Neuropathic Pain Market Report Key Takeaways from the Peripheral Neuropathic Pain Market Report Discover which therapies are expected to grab the major peripheral neuropathic pain market share @ Peripheral Neuropathic Pain Market Report Peripheral Neuropathic Pain Overview Peripheral neuropathies refer to conditions affecting peripheral nerve cells and fibers, arising from a variety of underlying causes. These nerves include the cranial nerves,...
PR Newswire
28/08/2024

iTeos to Participate in Upcoming Investor Conferences

2024 Wells Fargo Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetings Date: Wednesday, September 4, 2024 Time: 4:30 PM ET Location: Boston, M.A. Cantor Fitzgerald Global Healthcare ConferenceFormat: Fireside chat and one-on-one meetings Date: Wednesday, September 18, 2024 Time: 10:20 AM ET Location: New York, N.Y.A live webcast of the conference presentation will be available on the Investors section of the company's website at www.iteostherapeutics.com ...
Nasdaq GlobeNewswire
28/08/2024

Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare…

Alkermes Contact: Jamie ConstantineInvestor Relations+1 781 873 2402 Alkermes Contact: Jamie ConstantineInvestor Relations +1 781 873 2402 Logo -https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302233248.html
PR Newswire
28/08/2024

ClariMed Inc. Expands European Presence with New Office in Leeds, UK

Kelley Kendle, CEO of ClariMed, said that this new office location is a significant milestone in ClariMed's overall global growth strategy. "This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit," Kendle said. "Leeds' strategic location and thriving healthcare sector align perfectly with our mission to drive human-centered innovation in medical device development." Kelley Kendle, CEO of…
PR Newswire
28/08/2024

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and…

Bowen Therapeutics, which UTime intends to acquire, is a company dedicated to R&D of vaccines for infectious diseases. Its laboratory has previously published a number of research papers on monkeypox virus and has proposed a variety of potential vaccine designs. The Noval hexavalent recombinant protein vaccine developed through these studies has been designed based on the characteristics of monkeypox virus using the latest recombinant technology. The technology can effectively increase the…
PR Newswire
28/08/2024

Glass Cleaner Market to Reach $7.5 Billion, Globally, by 2032 at 6.2% CAGR…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A06984 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A06984 Prime determinants of growth The growth of the glass cleaner market is driven by several key factors. Firstly, the increasing focus on cleanliness and hygiene, particularly in households and commercial spaces, has led to a rising demand for effective glass cleaning products...
PR Newswire
28/08/2024

AC Immune's PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track…

AC Immune's PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative ConditionsPI-2620 is in Phase 3 development in Alzheimer's disease by AC Immune's partner, LMIThis Fast Track designation applies across Alzheimer's disease, progressive supranuclear palsy, and corticobasal degenerationFollows two previous Fast Track designations for ACI-35.030 and ACI-24.060 active immunotherapiesAffirms AC Immune's leadership and commitment to bringing...
Nasdaq GlobeNewswire
28/08/2024

MAYBELLINE NEW YORK ANNOUNCES SHAY MITCHELL AS NEWEST GLOBAL AMBASSADOR

A champion of self-expression and a true creative powerhouse, Mitchell will bring her unapologetic self to Maybelline New York as she begins her global ambassador role. A champion of self-expression and a true creative powerhouse, Mitchell will bring her unapologetic self to Maybelline New York as she begins her global ambassador role. "At Maybelline New York, we believe in the power of expressing your authentic self. Shay Mitchell embodies this value with a unique balance of strength…
PR Newswire
28/08/2024

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce…

As of 2019, there were approximately 18 million cases of rheumatoid arthritis globally. This condition predominantly affects women, who make up about 70% of those diagnosed. Additionally, over half of the individuals with this disease are aged 55 or older. Out of the total affected, around 13 million suffer from moderate to severe forms of rheumatoid arthritis, which indicates a potential need for rehabilitation. Rheumatoid arthritis is an autoimmune disorder that impacts various systems within…
PR Newswire
28/08/2024

ACG Inspection awarded GS1 Nigeria Gold Partnership

As an official Gold Partner of GS1 Nigeria, ACG can assist businesses in ensuring that they are NAFDAC compliant in time for the deadline in December 2024. As an official Gold Partner of GS1Nigeria, ACG can assist businesses in ensuring that they are NAFDAC compliant in time for the deadline inDecember 2024. The regulations established by the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) prohibit the sale of counterfeit, fake drugs and unwholesome...
PR Newswire
28/08/2024

LIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis…

"We are thrilled to welcome Scientis to LIAN Group's healthcare platform. With our hands-on approach, we are committed to accelerating Scientis' growth and sales in new markets. We will support management by leveraging our network, expertise and resources to expand into new markets, streamline operations, develop innovative products and services, and empower patients and healthcare professionals with high-quality solutions." says Fiorenzo Manganiello, Managing Partner of LIAN Group…
PR Newswire
28/08/2024

Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for…

Key Findings from the Phase 1 Clinical Trial: Key Findings from the Phase 1 Clinical Trial : Human serum albumin is essential for various medical treatments, such as volume replacement therapy for accidents, burns, and surgeries. However, the current supply is heavily dependent on blood donations, leading to potential shortages. Shilpa's rHA, produced using yeast fermentation, offers a highly purified, structurally and functionally equivalent alternative. "We are thrilled with the...
PR Newswire
28/08/2024

RYSE Asset Management invests in Curio Digital Therapeutics to support the…

Curio is currently working with health plans, insurers and corporate employee benefit plans in the US and India. They also work at a strategic level with pharma companies and others who seek to engage with Curio's data and underlying connected care platform which spans post-natal depression, fertility and menopause. Curio is currently working with health plans, insurers and corporate employee benefit plans in the US andIndia. They also work at a strategic level with pharma companies and...
PR Newswire
28/08/2024

KFSHRC Advances Diversity and Inclusion in Medical Education

RIYADH, Saudi Arabia, Aug.28, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) reaffirms its commitment to inclusivity and diversity in medical education, establishing itself as a leader in creating a learning environment that mirrors the global nature of modern healthcare. Housing professionals from over 77 nationalities, KFSHRC cultivates a vibrant culture of collaboration and knowledge sharing, sparking creativity and innovation essential for...
Nasdaq GlobeNewswire
28/08/2024

Vitestro Achieves CE Marking for Autonomous Blood Drawing Device

The CE marking underscores the safety, efficacy, and quality of Vitestro's innovative technology, which is set to revolutionize the way blood samples are collected. Through a combination of advanced imaging technology and robotics, the device enables hospitals and labs to provide accurate autonomous blood draws, reducing the need for manual handling and improving patient and clinician satisfaction. Vitestro has managed to automate the missing step in total lab automation. This is...
PR Newswire
28/08/2024

Aino Health reveals the top 10 real causes of sickness absence

Aino Health presents a nordic milestone to increase employee engagement and save millions of EUR, to secure tens of thousands of jobs in companies and to solve the acute staffing shortage in the public sector. "By understanding the real causes of sickness absence, companies can save millions while becoming more attractive and competitive" says Jyrki Eklund, CEO Aino Health. Being able to offer the right support to the right employees at the right time is crucial to creating a...
Nasdaq GlobeNewswire
28/08/2024

Keymed Biosciences Announces Interim Results for First Half of 2024

Stapokibart (CM310) (IL-4Rα antibody) Stapokibart (CM310) (IL-4Rα antibody) CMG901/AZD0901 (Claudin 18.2 ADC) CM313 (CD38 antibody) CM326 (TSLP antibody) CM355/ICP-B02 (CD20xCD3 bispecific antibody) CM336 (BCMAxCD3 bispecific antibody) CM350 (GPC3xCD3 bispecific antibody) CM369/ICP-B05 (CCR8 antibody) CM383 (Aβ protofibrils antibody) CM380 (GPRC5DxCD3 bispecific antibody) Financial and Business Highlights View original...
PR Newswire
28/08/2024

Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically…

Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C reduction 1 Results add to growing body of evidence for Leqvio across the ASCVD continuumData will be shared with regulatory agencies and presented at an upcoming medical meetingV-MONO is part of the 60,000-patient VictORION clinical trial program assessing Leqvio for primary and secondary ASCVD prevention Basel, August...
Nasdaq GlobeNewswire
28/08/2024

PCI Biotech first half 2024 interim results

Highlights reviewOperationsPCI Biotech's 2024 development goals are to demonstrate scalability and manufacturing process benefits for the photochemical-based technology (PCL) in viral vector manufacturing.Results reported in Q1 2024 from field testing of the technology with a European partner confirmed the potential benefit of applying photochemical methods in viral vector (AAV) manufacturing. These results are considered an important interim scalability milestone,...
Nasdaq GlobeNewswire
28/08/2024

Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO…

Best Practices Customer Value LeadershipAward forGlobal Biotech CRO Excellence. Avance Clinical CEO Yvonne Lungershausen thanked Frost & Sullivan for the global award and said they recognized the entire Avance Clinical team across the globe working together to accelerate clients' drug development.“Our agile, customer centric and integrated approach to progressing clinical research for our biotech clients is clearly resonating in an industry that too often has a one size fits all...
Nasdaq GlobeNewswire
28/08/2024
Altri  Comunicati